Lantheus Holdings, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Lantheus Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Debt due within a year is covered 528.6 times by its yearly operating cash. Higher than almost all Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 7.4 times. Higher than 93% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$142Over the last 3 years, every $100 of reported profit came with $142 of operating cash.
Lower than 55% of Healthcare companies in United States.
Self-Funding Ratio
7.4×Over the last 3 years its own operating cash covered its investment spending (capex) 7.4 times.
Higher than 93% of Healthcare companies in United States.
Cash Locked Ratio
$25For every $100 of sales, $25 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $24 tied up three years earlier.
More money tied up than 55% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$34Sales grew 65% in 3 years; of every extra $100 of sales, $34 became extra profit.
Higher than 60% of Healthcare companies in United States.
Asset Productivity Ratio
+65% / +69%In 3 years sales changed by +65% while total assets changed by +69%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
528.6×Debt due within a year is covered 528.6 times by its yearly operating cash.
Higher than almost all Healthcare companies in United States.
Cash Cushion Ratio
−4%Debt, after subtracting cash, equals 4% of its market value (net debt).
Lower than 73% of Healthcare companies in United States.
Tangible Assets Ratio
57%Of every $100 the company owns, $57 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 72% of Healthcare companies in United States.
Tangible Net Worth Ratio
12%Of every $100 of net worth, $12 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 68% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Lantheus Holdings, Inc. owes $0.46 for every $1 it owns. Net profit fell 25% in the year to Dec 2025, and grew 103% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
24.2Investors pay $24.2 for every $1 of Lantheus Holdings, Inc.'s yearly profit, lower than 55% of Healthcare companies in United States.
P/B ratio
4.98The share price is 4.98 times Lantheus Holdings, Inc.'s book value per share, higher than 72% of Healthcare companies in United States.
Market cap
$6.5 BThe total market value of all of Lantheus Holdings, Inc.'s shares at today's price (share price × number of shares), larger than 87% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$1.3 BWhat Lantheus Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$20.09Net worth divided by the number of shares. The share price of $100.10 is 5.0 times this, which is the P/B above.
Return on equity (ROE)
22.2%Lantheus Holdings, Inc. earned 22.2% on its shareholders' money over the last year, higher than 91% of Healthcare companies in United States.
Owes vs Owns
0.46×Lantheus Holdings, Inc. owes $0.46 for every $1 it owns (low), higher than 52% of Healthcare companies in United States.
Dividend yield
NoneLantheus Holdings, Inc. does not currently pay a dividend.
Revenue growth
+1%Revenue rose 1% in the year to Dec 2025, and grew 18% a year on average over 3 years.
Profit growth
-25%Net profit fell 25% in the year to Dec 2025, and grew 103% a year on average over 3 years.
Profit margin
15.2%Lantheus Holdings, Inc. keeps $15 of every $100 of revenue as net profit.
Cash quality
1.7×Cash from Lantheus Holdings, Inc.'s business was 1.7× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
16.0×Lantheus Holdings, Inc.'s operating profit covered its interest costs 16.0 times in the year to Dec 2025.
Cash vs debt
Net debtLantheus Holdings, Inc. had $260 M more debt than cash (net debt) at Dec 2025.
Questions
What is Lantheus Holdings, Inc.'s P/E ratio?
Investors pay $24.2 for every $1 of Lantheus Holdings, Inc.'s yearly profit, lower than 55% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Lantheus Holdings, Inc.: $6.5 B ÷ $1.3 B (30 Jun 2026) = 5.0.
What is Lantheus Holdings, Inc.'s return on equity?
Lantheus Holdings, Inc. earned 22.2% on its shareholders' money over the last year, higher than 91% of Healthcare companies in United States.
How much does Lantheus Holdings, Inc. owe compared with what it owns?
Lantheus Holdings, Inc. owes $0.46 for every $1 it owns (low), higher than 52% of Healthcare companies in United States.
Does Lantheus Holdings, Inc. pay a dividend?
No. Lantheus Holdings, Inc. does not currently pay a dividend.
Is Lantheus Holdings, Inc.'s revenue growing?
Revenue rose 1% in the year to Dec 2025, and grew 18% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.